KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership996,235 shares
Latest Disclosed Value $ 20,059,823
Geode Capital Management, Llc reports 5.52% increase in ownership of 4XC1 / KalVista Pharmaceuticals, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 996,235 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $15,441,642 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 944,077 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of 5.52% during the quarter. The current value of the position is $22,923,367 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 996,235 52,158 5.52 20,060 31.53 0.0007
2026-02-09 2025-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 944,077 15,406 1.66 15,251 34.81 0.0005
2025-11-12 2025-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 928,671 -12,541 -1.33 11,314 6.31 0.0007
2025-08-08 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 941,212 25,971 2.84 10,642 0.74 0.0007
2025-05-13 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 915,241 92,889 11.30 10,565 51.65 0.0008
2025-02-12 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 822,352 -8,632 -1.04 6,967 -27.62 0.0005
2024-11-12 2024-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 830,984 24,713 3.07 9,624 1.32 0.0008
2024-08-09 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 806,271 154,383 23.68 9,499 22.85 0.0008
2024-05-13 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 651,888 21,840 3.47 7,732 0.18 0.0007
2024-02-13 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 630,048 108,157 20.72 7,719 53.56 0.0008
2023-11-13 2023-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 521,891 41,466 8.63 5,026 16.26 0.0006
2023-08-11 2023-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 480,425 12,941 2.77 4,324 17.66 0.0005
2023-05-15 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 467,484 69,409 17.44 3,674 183,600.00 0.0005
2023-02-13 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 398,075 -16,784 -4.05 3 -99.97 0.0004
2022-11-14 2022-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 414,859 17,844 4.49 6,019 54.10 0.0009
2022-08-12 2022-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 397,015 -12,011 -2.94 3,906 -35.21 0.0006
2022-05-13 2022-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 409,026 31,056 8.22 6,029 20.58 0.0008
2022-02-11 2021-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 377,970 9,830 2.67 5,000 -22.17 0.0006
2021-11-12 2021-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 368,140 30,863 9.15 6,424 -20.50 0.0009
2021-08-13 2021-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 337,277 10,010 3.06 8,081 -3.88 0.0011
2021-05-12 2021-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 327,267 101,848 45.18 8,407 96.43 0.0013
2021-02-12 2020-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 225,419 17,542 8.44 4,280 63.55 0.0007
2020-11-13 2020-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 207,877 9,592 4.84 2,617 9.09 0.0005
2020-08-13 2020-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 198,285 6,616 3.45 2,399 63.64 0.0005
2020-05-14 2020-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 191,669 27,763 16.94 1,466 -49.78 0.0004
2020-02-20 2019-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 163,906 12,125 7.99 2,919 65.85 0.0006
2020-02-13 2019-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 163,906 12,125 2,919 372.0010
2019-11-12 2019-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 151,781 9,912 6.99 1,760 -43.98 0.0004
2019-08-14 2019-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 141,869 58,774 70.73 3,142 32.13 0.0008
2019-05-14 2019-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 83,095 -786 -0.94 2,378 43.60 0.0006
2019-03-06 2018-12-31 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 83,881 19,636 30.56 1,656 16.70 0.0005
2019-02-13 2018-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 83,881 19,636 1,656
2018-11-13 2018-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 64,245 43,483 209.44 1,419 744.64 0.0004
2018-08-14 2018-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 20,762 0 0.00 168 -14.29 0.0001
2018-05-15 2018-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 20,762 0 0.00 196 -2.97 0.0001
2018-02-13 2017-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 20,762 20,762 202 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.